The Goldman Sachs Group, Inc. 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-09 12:28 pm Sale | 2025-03-31 | 13G | GeneDx Holdings Corp. WGS | GOLDMAN SACHS GROUP INC GS | 1,106,752 3.900% | -315,151 (-22.16%) | Filing |
| 2025-02-05 4:05 pm Purchase | 2024-12-31 | 13G | GeneDx Holdings Corp. WGS | GOLDMAN SACHS GROUP INC GS | 1,421,903 5.200% | 84,798 (+6.34%) | Filing |
| 2024-11-08 11:06 am Sale | 2024-09-30 | 13G | GeneDx Holdings Corp. WGS | GOLDMAN SACHS GROUP INC GS | 1,337,105 5.000% | -486,632 (-26.68%) | Filing |
| 2024-02-09 7:10 pm Purchase | 2023-12-29 | 13G | GeneDx Holdings Corp. WGS | GOLDMAN SACHS GROUP INC GS | 1,823,737 7.000% | 1,823,737 (New Position) | Filing |